Furthermore, EMP treatment significantly reduced the levels of blood glucose and insulin in serum and improve glucose intolerance and insulin resistance in T2D rats, suggesting that EMP may also have a regulatory effect on hepatic glucose metabolism. The gene discussed is INS; the disease is Glucose intolerance.